Published June 11, 2021
The purpose of this series is to explain the connections between the Chinese Communist Party’s virology research programs since 2005 and the research institutions involved, including those in Hong Kong. All information is sourced from the Internet. The analysis and conclusions presented here reflect author’s own views only.
Below is an excerpt from the original report Disclosure Report on CCP’s Virus Research Programs and Projects, edited to fit for publishing online.
In this series, we examine the blueprint of the CCP’s virus research program by focusing on the research program titled Research on Cross-Species Infection and Transmission Mechanism of Major Outbreak of Human-Animal Infections with Animal Origin (hereinafter referred to as the 2016 Virus Program).
The 2016 Virus Program is part of the CCP’s 973 Program and Five-Year Plan, and is closely linked to the Infectious Diseases Control and Prevention Special Program (IDCPSP). In this part, we examine the connections between 2016 Virus Program and the IDCPSP.
The Infectious Disease Control and Prevention Special Program (IDCPSP)
The IDCPSP (full name Prevention and Control of Major Infectious Diseases such as AIDS and Viral Hepatitis), is a sub-program of the National Science and Technology Major Project, managed by China’s Ministry of Science and Technology of the State Department. According to the National Medium- and Long-term Scientific and Technological Development Plan (2006-2020), this special program is a national-level infectious disease prevention and control program led by the former Ministry of Health of the China’s State Department (now the National Health Commission) and the Health Bureau of the Logistics and Security Department of the Central Military Commission of the CCP. The implementation period is 2008-2020, with a number of new projects set up every year, whose implementation period varies from 2 to 5 years. The IDCPSP is funded by grants from the Ministry of Finance and the National Natural Science Foundation.
From the public information released by the Chinese government, we found the following list of the groups involved in the IDCPSP for the period of 2016-2020:
(Texts in the picture translated below:
List of General Group Members of “Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis” Special Program under the “13th 5-year Plan”
Hou Yunde Chinese Center for Disease Control and Prevention, Academician of Chinese Academy of Engineering
Deputy Chief Engineer:
Xu Jianguo Chinese Center for Disease Control and Prevention, Academician of Chinese Academy of Engineering
Li Lanjuan Zhejiang University, Academician of the Chinese Academy of Engineering
Wang Hongyang Second Military Medical University, Academician of Chinese Academy of Engineering
Members: (in the order of number of strokes in the surname)
Wang Yuguang Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Wang Youchun National Institutes for Food and Drug Control
Wang Jianwei Chinese Academy of Medical Sciences
Wang Fusheng PLA Hospital No. 302, Chinese Academy of Sciences
Cheng Shiming Chinese Center for Disease Control and Prevention
Zhu Guofeng Shanghai Center for Disease Control and Prevention
Bing Sun Shanghai Pasteur Institute, Chinese Academy of Sciences
Wu Hao Beijing You’an Hospital, Capital Medical University
Wu Kaicun Fourth Military Medical University
Wu Jianmin Wuhan University
Shen Xinliang China Biotechnology Co.
Wei Chen Institute of Biological Engineering, Academy of Military Medical Sciences
Chen Xinwen Wuhan Institute of Disease and Reproductive Health, Chinese Academy of Sciences
Fan Ji-Ping Chinese Academy of Traditional Chinese Medicine
Jin Qi Institute of Pathogen Biology, Chinese Academy of Medical Sciences
Yuan Zhenghong Fudan University
Jia Jidong Beijing Friendship Hospital, Capital Medical University
Ning Shao Xia Xiamen University
Gao Fu Chinese Center for Disease Control and Prevention, Chinese Academy of Sciences
Siyan Zhan Peking University
Mengfeng Lai Zhongshan University
Wei Lai People’s Hospital of Peking University
Qu Jieming Ruijin Hospital, Shanghai Jiaotong University School of Medicine )
Note that all the expert members in the 2016-2020 General Group list are top researchers from China’s research institutions in the fields of infectious diseases, virology, immunology, and proteomics. Many of them are also leaders in IDCPSP and its sub-programs. In addition to this list, there is also a list called Third National Committee of Experts on Biosafety Assessment of Human Infectious Microbiological Laboratories issued by China in January 2021 (see reference for the original document), whose members, along with their research directions and affiliated institutions, warrant further investigation.
More connections to the 2016 Virus Program can be seen when we consider the fact that ZC45 and ZXC21, identified by Dr. Li-Meng Yan in 2020 as the backbone of the COVID-19 virus, are the results of research conducted by Wang Changjun(王长军)’s team at the Nanjing Military Medical Research Institute of the PLA in 2017. The research was funded by the 2013 IDCPSP, (project number2013ZX10004103-104). Details of this project cannot be found from any of the Chinese government website.
Also, a document titled 13th 5-year Plan on the Prevention and Control of Sudden Acute Infectious Diseases (2016-2020), issued by China government in 2016 (see reference for original document), states the following:
“The Party Central Committee and the State Department pay great attention to the prevention and treatment of sudden acute infectious diseases, requiring that the health and safety of the general public always take the top priority, and mandating effectively prevention and control of infectious diseases and public health emergencies. Also the prevention and treatment of sudden acute infectious diseases should be treated as a matter of national security. With the steady advancement of the “Belt and Road” strategy and the needs of national security and development, China will take on more international obligations and responsibilities than before, and participation in global health emergency response outside China will gradually become the new norm. To this end, during the 13th 5-Year Plan period, we must improve our capability and skill-level in prevention and treatment of acute infectious diseases in all aspects, so as to effectively ensure comprehensive, coordinated and sustainable economic and social development.”
The above shows that in addition to implementing the “One Belt, One Road” strategy which attempts to expand its communist model to the world, CCP is also attempting to implement a viral version of the “One Belt, One Road” strategy in the field of world public health. The “One World, One Health” concept proposed by the CCP, as explained later in this series, and the regional cooperation with the “Belt and Road” countries, as well as the cooperation among the Mainland, Hong Kong, Macao, and Taiwan, fully illustrate that the 13th 5-Year Plan is a sign that the CCP has officially begun to actively seek expansion in the area of world public health.
In addition to the documents mentioned above, this series also collects as much publicly available government information as possible on the IDCPSP (published in later parts of this series), to serve as references for other COVID-19 investigators.
Apart from the 973 Program, other CCP’s virology research programs, such as Disease Control and Prevention Special Program, might have played a part in the CCP’s bio-weapon research as well. Meanwhile, documents from the CCP reveals its ambition of expanding its Belt-and-Road Initiative into the world public health domain.
Proofread: DT团队 & 文永
Cover photo: GNews海报组 Deem
Other articles in this series: